Benjamin v. Glaxosmithkline LLC
Benjamin v. Glaxosmithkline LLC is a federal personal property / fraud lawsuit filed on 10/03/2023 in the District Court, E.D. Pennsylvania. The case was terminated on 12/19/2023.
- Court
- District Court, E.D. Pennsylvania (E.D. Pa.)
Official Court Website → - Assigned judge
- Kai N. Scott · 99 cases in index
- Docket number
- 2:23-cv-03856
- Cause
- 28:1332 Diversity-Fraud
28 U.S.C. § 1332 — Diversity jurisdiction - Nature of suit
- 370 Other Fraud
Fraud or misrepresentation claims not covered by a more specific category. - Jurisdiction
- Diversity
- Jury demand
- Plaintiff
- Date filed
- 10/03/2023
- Date terminated
- 12/19/2023
3,960 Personal Property / Fraud cases in this court are indexed here.
Parties
- plaintiff · Benjamin · 602 cases
- defendant · GlaxoSmithKline LLC · 2765 cases
Part of a Larger Litigation Pattern
This is one of 2,766 Personal Property / Fraud cases in our index naming GlaxoSmithKline LLC — a possible mass-tort or coordinated-litigation cluster.
About Personal Property / Fraud Lawsuits
These cases involve damage to or loss of personal property, or claims of fraud and misrepresentation — including truth-in-lending and other deception-based claims.
Frequently Asked Questions
What is Benjamin v. Glaxosmithkline LLC?
Benjamin v. Glaxosmithkline LLC is a federal personal property / fraud lawsuit filed on 10/03/2023 in the District Court, E.D. Pennsylvania. The case was terminated on 12/19/2023. These cases involve damage to or loss of personal property, or claims of fraud and misrepresentation — including truth-in-lending and other deception-based claims.
What type of case is this?
It is classified as “Personal Property / Fraud” under the federal nature-of-suit system. These cases involve damage to or loss of personal property, or claims of fraud and misrepresentation — including truth-in-lending and other deception-based claims.
What court is the case in?
The case is in the District Court, E.D. Pennsylvania, docket number 2:23-cv-03856.
When was the case filed?
Benjamin v. Glaxosmithkline LLC was filed on 10/03/2023. It was terminated on 12/19/2023.
What law is the case brought under?
The docket lists the cause as 28 U.S.C. § 1332 — Diversity jurisdiction.
Other Cases Involving These Parties
Related Personal Property / Fraud Cases
Source: public U.S. federal court record (docket 67852368).